VEGF is a prototype angiogenic factor, but recent evidence indicates that this growth factor also has direct effects on neural cells. Abnormal regulation of VEGF expression has now been implicated in several neurodegenerative disorders, including motoneuron degeneration. This has stimulated an increasing interest in assessing the therapeutic potential of VEGF as a neuroprotective agent for such neurodegenerative disorders.
Koen Poesen, Diether Lambrechts, Philip Van Damme, Joke Dhondt, Florian L. P. Bender, Nicolas Frank, Elke Bogaert, Bart Claes, Line Heylen, An Verheyen, Katrien Raes, Marc Tjwa, Ulf Eriksson, Masabumi Shibuya, Rony Nuydens, Ludo Van Den Bosch, Theo Meert, Rudi D’Hooge, Michael Sendtner, Wim Robberecht, Peter Carmeliet
Joke Dhondt, Eve Peeraer, An Verheyen, Rony Nuydens, Ian Buysschaert, Koen Poesen, Katie Van Geyte, Manu Beerens, Masabumi Shibuya, Jody J. Haigh, Theo Meert, Peter Carmeliet, Diether Lambrechts
Discussion(0)
No comments yet. Be the first to comment.